Trending/Rebiotix
Mayo Clinic enrolls first patient in phase 1 study of orally delivered capsule to treat recurrent Clostridium difficile infection
ROCHESTER, Minn. – Mayo Clinic announced today that it has enrolled the first patient in a phase one study of a unfrozen oral capsule formulated…
No information found.
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community